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622Objectives: Bicuspid aortic valves are associated with aortic catastrophes, particularly dissection.We examined
whether proactive repair of associated dilatation would reduce risk of subsequent aortic dissection or reoperation
and whether more aggressive resection is needed in patients undergoing bicuspid aortic valve surgery alone.
Methods: From January 1993 to June 2003, 1989 patients (of our total experience of 4316) underwent bicuspid
aortic valve surgery. Long-term outcomes of 1810 were analyzed according to aortic size and whether bicuspid
aortic valve surgery was performed alone or with aortic repair.
Results: In-hospital 30-day survival was similar (98.8% valve alone vs 98.9%with aortic repair), with no penalty
incurred for concomitant aortic repair. Bicuspid aortic valve–alone patients had worse late survival (75% vs 85%
at 10 years, P¼ .0001), but in the matched cohort survival was nearly identical (85% vs 86%; P ¼ .7). With this
strategy, freedom from late aortic events was high in both groups (99% valve alone vs 97%with aortic repair at 10
years; P[log-rank] ¼ .06) and similar in the matched cohort (95% vs 97%; P ¼ .2). Approximately 95% of pa-
tients undergoing valve-alone surgery had aortic diameters smaller than 4.6 cm or cross-sectional area/height ratios
less than 9.4 cm2/m; 80% undergoing valve surgery plus aortic repair had diameters larger than 4.1 cm or ratios
greater than 7.3 cm2/m. Only 0.2% of events occurred at an aortic diameter size of less than 4.5 cm.
Conclusions:Aortic size larger than 4.5 cm or aortic cross-sectional area/height ratio greater than 8 to 10 should
be considered triggers for concurrent aortic repair, because there is no added risk, and late survival is better;
however, more aggressive resection is unwarranted. (J Thorac Cardiovasc Surg 2011;142:622-9)Supplemental material is available online.
Bicuspid aortic valves are present in 1% to 2% of the
population and are associated with aortic valve stenosis
and regurgitation, resulting heart failure, valve surgery at
an earlier age than in those with tricuspid valves, and
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The Journal of Thoracic and Cardiovascular Surgaortic aneurysm, and aortic dissection.1-8 Aortic dissection,
particularly in patients with bicuspid valves, carries a high
risk of immediate death and death during emergency
surgery and is associated with considerably reduced late
survival.1,7,9 Of those patients with acute dissection, 15%
have bicuspid aortic valves.7 Among patients with bicuspid
aortic valves, aortic dissection occurs in 12%with aortic di-
ameter smaller than 5.0 cm,9 which is similar to the 15%
prevalence seen among patients with Marfan syndrome
with aortic diameter smaller than 5.0 cm.10 Indeed, when
the ratio of aortic cross-sectional area (square centimeters)
divided by height (meters) is greater than 10, risk of dissec-
tion increases for both groups.9,10 Furthermore, shorter
patients are more prone to dissection at an equivalent
aortic size.9,10 Timing of surgery and procedures
continues to be debated, with some authors advocating
surgery at an aortic size larger than 5.5 cm and others at
smaller than 4.5 cm.9-19
The aims of this study were as follows: (1) to identify dif-
ferences between patients undergoing bicuspid aortic valve
surgery alone and those for whom concomitant ascending
aortic repair was performed, with particular emphasis on
determining whether various methods of indexing aortic
valve size to body size might differentiate these groups of
patients, and (2) to evaluate early and late risk-adjusted out-
comes of patients undergoing bicuspid aortic valve surgery
with or without a proactive approach to repairing theery c September 2011
Abbreviations and Acronyms
CI ¼ confidence interval
CT ¼ computed tomography
MRI ¼ magnetic resonance imaging
Svensson et al Acquired Cardiovascular Diseaseascending aorta. Specifically, we examined whether con-
comitant repair of the ascending aorta can be done safely,
whether aortic dimensions matter, how this approach influ-
ences late outcome, and whether even more aggressive
surgery is needed.A
C
DMATERIALS AND METHODS
From January 1993 to June 2003, 1989 patients underwent bicuspid aor-
tic valve surgery at ClevelandClinic (our total experiencewith bicuspid aor-
tic valves is 4316 patients, of whom 771 underwent repair); among them,
1810 preoperative echocardiograms suitable for ascending aorta measure-
ment were available (echocardiograms in which the ascending aorta was
not adequately imaged were excluded). This interval was chosen to allow
long-term follow-up and also because during this period indications for con-
comitant aortic resectionwere not clearly defined, and thus therewas greater
heterogeneity in resecting the aorta according to size. Among the 1810 pa-
tients with suitable echocardiograms, 1449 (80%) had bicuspid aortic valve
surgery alone (valve-alone group), and 361 (20%) had bicuspid aortic valve
surgery plus concomitant ascending aortic repair (valve–aorta group). As-
cending aortic procedures performed included composite valve tube graft
in 208 cases, ascending aorta tube graft in 117, and root procedure plus aor-
tic valve repair in 36. During this time, 245 patients had bicuspid aortic
valves repaired. Since then, however, the proportion of patients undergoing
repair has increased because of improved techniques and results.1,3,4,15
Mean age in the valve-alone group was 56 15 years (range, 18–90 years),
and 76% were men; in the valve–aorta group, mean age was 54 14 years
(range, 20–86 years), and 82% were men (Table E1).
Patient and procedure variables were entered prospectively into the
Cleveland Clinic Cardiovascular Information Registry. Use of these regis-
try data for research was approved by the Institutional Review Board, with
patient consent waived.
Echocardiographic Measurements
In the preoperative parasternal long-axis transthoracic echocardio-
graphic view, the ascending aorta was measured 1 to 2 cm above the sino-
tubular junction. All echocardiograms were reviewed and measured by one
of us (K.-H.K.). We were interested to see whether various methods of
indexing aortic size to height or body surface area might differentiate
between patients who had undergone valve-alone versus combined
valve–aorta operations (Table 1). Size of the ascending aorta was analyzed
in 3 ways. The first was simply its diameter, as measured echocardiograph-
ically. The second normalized the diameter and circularized area (in square
centimeters) derived from this to patient height.9,10 The third standardized
the degree of normality of ascending aorta dimension according to the body
surface area of the patient. This was expressed as a Z value, the number of
SDs that the patient’s aortic diameter deviated from mean normal
dimension (95% of normal individuals are within 2 and þ2 Z units).
Other expressions were also examined (Table E2). Routine transesophageal
echocardiography was done intraoperatively.
Computed tomography. Computed tomography (CT) and mag-
netic resonance imaging (MRI) were done only for patients with suspected
aortic aneurysm. These data were therefore not available for all patients in
this study. Nevertheless, echocardiographic imaging was available for mostThe Journal of Thoracic and Caof the ascending aorta and aortic root and was routinely recorded, as de-
scribed in the preceding text. Among patients who had aneurysms, most un-
derwent further imaging by CTorMRI; if aneurysms were not significantly
enlarged on echocardiography, however, further imaging may not have
been performed. We therefore used echocardiography for preoperative
assessment. CT or MRI would have shown any arch or descending aorta
involvement or coarctation. Because this was a retrospective study and
patients were followed by referring physicians, routine late CT or MRI
studies were not performed.
Surgery. Valve-alone procedures were performed on the basis of patient
symptoms or evidence of left ventricular deterioration. If the predominant le-
sion was aortic valve regurgitation, then the valve was evaluated for possible
repair according to a Commissure, Leaflet, Annulus, Sinuses, Sinotubular
(CLASS) schema.3,15 The decision to perform combined valve and aorta
resection was based on aortic size and the quality of each patient’s aorta.
The quality of the aorta was subjectively assessed by surgeons based on
wall thickness, ability to hold sutures, and whether a potential dissection
plane was visible in the media. During this period, the approach to repair
the aorta was heterogeneous and was based on the judgment of the
surgeon. This gives strength to the study in that no specific cutoff point
was used. Although many patients had ascending aorta tube grafts, if the
root was enlarged substantially, a composite valve graft was inserted or an
aortic root remodeling or modified David reimplantation procedure was
performed.3,4,8,13,15 A minimally invasive incision was preferred for both
valve-alone and combined valve–aorta repairs. The typical repair technique
for bicuspid valves was placement of Cabrol sutures at the commissures,
plication of clefts, release of raphe, and leading-edge figure-of-8 sutures,
as described previously.15
Outcomes
Outcomes considered were in-hospital mortality, long-term events re-
lated to the ascending aorta, and long-term all-cause mortality. Patients
were followed up systematically at 2-year intervals, supplemented by
a cross-sectional follow-up by Institutional Review Board–approved mailed
questionnaire or telephone interview requiring patient consent, with empha-
sis on assessing events related to the aorta, including ascertaining mode of
death. Mean follow-up was 5.9  3.6 years for the valve-alone group and
6.7  3.6 years for the valve–aorta group, with 10% followed up longer
than 11 years; 8550 and 2411 patient-years of data were available for
analysis, respectively. Data on vital status were augmented with the Social
Security Death Index,20,21 yielding mean follow-up for vital status of 9.2
 4.0 years for the valve-alone group and 9.0 3.4 years for the valve–aorta
group. Seventy-five patients (4.1%) were unavailable for follow-up, and all
were checked for death with the Social Security Death Index.Data Analysis
Differences between valve-alone and valve–aorta
patients. Data analysis first addressed dissimilarities between the
valve-alone and valve–aorta groups (Table E1), so that comparisons of out-
come were fair. Briefly, multivariable logistic regression analysis was used
to identify a parsimonious set of patient and procedure variables associated
with combined valve and aorta surgery versus valve surgery alone. Bagging
was used for variable selection (see Appendix for variables considered),22
with automated analysis of 1000 bootstrap samples and a P value for reten-
tion of .05. Frequency of occurrence of individual factors or clusters of
highly correlated factors in these analyses was counted (aggregation
step), and factors appearing in 50% or more of the analyses were consid-
ered reliably statistically significant at P .05. To this parsimonious model
were added nonsignificant variables representing groups of patient, coro-
nary disease, valve pathology, and surgical procedure variables that might
be related to unrecorded selection factors (saturated propensity model).23
Because preoperative diagnostic aneurysm and dilated aorta variables act
as surrogates for group membership, they were not included in therdiovascular Surgery c Volume 142, Number 3 623
TABLE 1. Factors associated with higher likelihood of undergoing
bicuspid aortic valve surgery and ascending aorta repair
Factor Estimate ± SE P Reliability (%)*
Larger ascending aorta
diametery
21  1.3 <.0001 100
Emergency operation 1.9  0.59 .001 77
No LCx disease 0.63  0.19 .0008 95
Lower AV stenosis grade 0.15  0.033 <.0001 87
Nonsevere LV dysfunctionz 0.023  0.010 .02 54
More recent date of
operation
0.13  0.029 <.0001 93
AV, Aortic valve; LCx, left circumflex; LV, left ventricular; SE, standard error.
*Percentage of times factor appeared in 1000 bootstrap models. y(Height/diameter),
inverse transformation. Ascending aortia diameter normalized by patient height.
z(LV dysfunction grade)2, squared transformation.
FIGURE 1. Cumulative distribution of ascending aorta size at bicuspid
aortic valve surgery. Vertical axis represents nonparametric percentile;
thus, the value for ascending aorta diameter at the 50% point on the vertical
axis is the median value (50th percentile), the values at 10% and 90% are
the 10th and 90th percentiles, and so forth. A, Diameter. B, Area/height
ratio. BAV, Bicuspid aortic valve surgery alone; BAVþAo, bicuspid aortic
valve surgery and ascending aorta repair.
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culated for each patient (C ¼ .90).
Propensity matching. Using only the propensity score, patients from
the valve–aorta group were matched 1:1 with patients from the valve-alone
group with a greedy matching strategy. Patients in the valve–aorta group
whose propensity scores deviated more than approximately 0.2 from those
of patients in the valve-alone group were considered unmatched; 206 well-
matched pairs (57%) were obtained.
Comparison of early outcomes. Because there were few in-
hospital deaths or strokes, we performed focused logistic regression analysis
with treatment group and ascending aorta size variables included in the
model, along with propensity score, as covariables for risk adjustment.24
Comparison of time-related outcomes. Freedom from long-
term events related to the ascending aorta and survival estimates were ob-
tained using the Kaplan–Meier nonparametric method. A parametric
method was used to resolve the number of phases of instantaneous risk
(hazard function) and to estimate shaping parameters.25 (For additional
details, see http://my.clevelandclinic.org/professionals/software/hazards/
default.aspx.) Because this was a retrospective study, patients who had val-
vular disease alonewould have been followed up only by echocardiography
unless there was evidence of aneurysmal formation. Longitudinal CT or
MRI data were therefore not available for following any potential aortic
growth other than those detected by echocardiography or incidental CT
or MRI that in turn resulted in referral for reoperation.
Data Presentation
Continuous variables are summarized as mean SD, or equivalently as
15th, 50th, (median), and 85th percentiles when the distribution of values
was skewed. Categoric variables are summarized as frequencies and per-
centages. Continuous variables were compared using the Wilcoxon rank-
sum test. Categoric variables were compared using the c2 test when the
smallest number of individuals in a category was more than 5 and with
Fisher’s exact test otherwise. Freedom from events related to ascending
aorta and survival estimates are accompanied by asymmetric 68% confi-
dence limits, equivalent to  1 SE.
RESULTS
Differences Between Valve-Alone and Valve–Aorta
Patients
Patients in the valve–aorta group were more likely than
those in the valve-alone group to undergo emergency
surgery and were less likely to have circumflex coronary624 The Journal of Thoracic and Cardiovascular Surgartery disease, aortic valve stenosis, or left ventricular dys-
function. They were operated on more frequently and had
larger aortic diameters (with similar C-statistics for aortic
diameter or area normalized to height [C¼ .86] or standard-
ized to Z value [C ¼ .85]; Table 1).
Heterogeneity of decision making resulted in wide over-
lap of ascending aorta size, however expressed (Figure 1,
Table E2). Nevertheless, patients with aortic diameters
larger than 4.2 cm frequently underwent aortic replacement
(Figure 1, A), and at approximately 4.7 cm, 100% had
replacement. Similarly, at an aortic cross-sectional area/
height ratio of 8 to 9 cm2/m, the aorta was increasingly re-
placed; at a value of 10, virtually all patients underwent aor-
tic replacement (Figure 1, B). Above a Z value ofþ5, the
aorta was increasingly replaced; above þ8, nearly 100%
were replaced (Figure E1).ery c September 2011
FIGURE 2. Nonparametric Kaplan–Meier estimates of freedom from
events related to ascending aorta. Note that vertical axis is greatly ex-
panded, from 90% to 100%. Each circle represents an aortic event after
bicuspid aortic valve repair alone; each square represents an aortic event
after combined valve–aorta procedure, positioned along vertical axis by
Kaplan–Meier estimator. Vertical bars represent  1 SE, and numbers in
parentheses designate patients remaining at risk. A, Whole cohort. B,
Matched cohort. BAV, Bicuspid aortic valve surgery alone (circles); BAVþ
Ao, bicuspid aortic valve surgery and ascending aorta repair (squares).
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DHospital Mortality and Morbidity
Unadjusted hospital mortality was 1.1% (CL, 0.58%–
2.0%) for the valve–aorta group versus 1.2% (CL, 0.95%–
1.6%, P>.9) for the valve-alone group. Risk of stroke was
similar at 1.7% and 1.3%, respectively (P ¼ .6). There was
no statistically significant difference between groups with re-
spect to return to the operating room for bleeding, myocardial
infarction, or renal failure (Table E3).
In propensity-matched patients, mortality and morbidity
figures were similar for both groups (P>.9). Propensity-
adjusted analysis corroborated this, showing that neither
ascending aorta surgery nor ascending aorta diameter influ-
enced in-hospital death or risk of stroke (Table E4).Follow-up Events Related to Ascending Aorta
On follow-up, there were 14 events related to the aorta, 8
in the valve-alone group and 6 in the valve–aorta group.The Journal of Thoracic and CaValve-alone group (n¼ 1449) events were (1) 1 reoperation
for aortic dissection at 14 days, (2) 1 death from aortic dis-
section 4.1 months after the patient refused reoperation,
(3) 1 dissection reoperated 2.3 years after surgery, (4) 1 distal
aortic aneurysm at 4.6 years, (5) 1 reoperation for ascending
aorta aneurysm at 5.5 years, (6) 1 root aneurysm at 6.3 years,
(7) 1 root aneurysm at 6.4 years, and (8) 1 dilated ascending
aorta at 11.5 years. Aortic diameters, cross-sectional area/
height ratios, and Z values before surgery were 4.6 cm, 5.2
cm, 4.0 cm, 4.8 cm, 4.7 cm, 3.1 cm, 6.0 cm, and 4.2 cm;
9.1 cm2/m, 14 cm2/m, 7.0 cm2/m, 9.7 cm2/m, 9.9 cm2/m,
4.8 cm2/m, 16 cm2/m, and 7.8 cm2/m; and 6.4, 9.0, 5.3,
6.1, 6.5, 3.7, 9.4, and 6.1 Z, respectively. Thus, for the
valve-alone group, nonparametric Kaplan–Meier estimates
of freedom from aortic events at 1, 5, and 10 years were, re-
spectively, 99.8%, 99.7%, and 99%. Of note, only 3 of 1449
patients (0.2%) in the valve-alone group had aortic events
after operation at an aortic diameter smaller than 4.5 cm.
In the valve–aorta group (n¼ 361), aortic events were (1)
1 death from aortic dissection at 2 days, (2) 1 death from
dissection beyond an allograft 14 days after surgery, (3) 1
reoperation for root aneurysm 2.4 years later, (4) 1 reopera-
tion for root aneurysm 3.5 years later, (5) 1 reoperation for
root aneurysm 4.7 years later, and (6) 1 reoperation for di-
lated aorta 9.5 years later. Aortic diameters, cross-
sectional area/height ratios, and Z values before surgery
were 6.0 cm, 4.9 cm, 5.2 cm, 3.6 cm, 4.5 cm, and 3.2 cm;
15 cm2/m, 12 cm2/m, 13 cm2/m, 5.6 cm2/m, 8.8 cm2/m,
and 4.5 cm2/m; and 8.5, 9.1, 8.6, 4.1, 5.9, and 2.5 Z, respec-
tively. Of note, only 3 patients developed a root aneurysm,
and only 1 underwent reoperation for late arch aneurysm.
Thus, for this latter group, nonparametric Kaplan–Meier
estimates of freedom from aortic events at 1, 5, and 10 years
were, respectively, 99.4%, 98.4%, and 97.1%. Risk-
unadjusted comparison shows that patients in the valve–
aorta group were somewhat more likely to have aortic
events than were those in the valve-alone group (P[log-
rank] ¼ .06; Figure 2, A). Matched comparison, however,
shows freedom from ascending aorta–related events to be
similar (P[log-rank] ¼ .2; Figure 2, B). Thus, based on
the decision making described, reintervention on the aorta
was rare for both groups. That is, later reoperation for aneu-
rysm repair was rare for valve-alone procedures, and false
aneurysms or late complications were also rare for com-
bined valve–aorta procedures.
Long-Term Survival
Risk-unadjusted survival after combined valve–aorta
procedures was better (85% 10-year survival) than after
valve-alone surgery (75% 10-year survival, P[log-
rank] ¼ .0001; Figures 3, A, and E2), probably because of
more severe symptoms in thevalve-alone patients, associated
with more severe aortic valve stenosis andworse left ventric-
ular function (Tables 1 and E1). For the propensity-matchedrdiovascular Surgery c Volume 142, Number 3 625
FIGURE 3. Survival for both groups. Format is as in Figure 2. Solid lines
are parametric estimates enclosed within 68% confidence limits. A, Whole
cohort. B, Matched cohort. BAV, Bicuspid aortic valve surgery alone
(circles); BAVþAo, bicuspid aortic valve surgery and ascending aorta re-
pair (squares).
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survival was nearly identical (10-year survival 86% vs
85% and 15-year survival 74% vs. 79%, respectively, P
[log-rank] ¼ .6; Figure 3, B), including for ventricular dys-
function.An important caveat is that propensitymatching ad-
justed for preoperative symptoms, aortic valve disease, and
ventricular dysfunction differences. There were no differ-
ences in survival or aortic complications according to repair
or replacement of the valve, root procedure, or valve type
(mechanical vs biologic).
DISCUSSION
Principal Findings
This study evaluated patients operated on during a period
when no strict guidelines existed concerning when to resect
the ascending aorta during bicuspid aortic valve procedures.
Hence, there were some intersurgeon differences in the ap-
proach to management of a dilated aorta that resulted in
a spectrum of procedures based on the initial diameter.
Our results thus show that at an absolute diameter of 4.5
cm or greater or a cross-sectional area/height ratio higher
than 8 cm2/m, the aorta can be safely resected without626 The Journal of Thoracic and Cardiovascular Surgadded penalty. However, the recent trend of recommending
more aggressive resection of the aorta when smaller than
4.5 cm, or concurrently the aortic root, or electively the aor-
tic arch, cannot be justified on the basis of this study. In-
deed, only 1 patient with aortic diameter smaller than 4.5
cm required reoperation for aortic dissection. We therefore
cannot justify the added risks of root resection with coro-
nary reimplantation, or aortic arch resection with circula-
tory arrest and no concurrent significant aneurysmal
dilatation beyond 4.5 cm. Of interest, this study has also
shown pari passu that patients operated on under current
valve guidelines when they start to show symptoms or
have developed left ventricular dysfunction have poorer
late survival than less symptomatic patients (valve–aorta
group). This raises the issue of whether severe bicuspid
valve disease, as with mitral valve disease, should be ad-
dressed before development of symptoms or left ventricular
dysfunction.
Bicuspid aortic valve is among the most common con-
genital cardiac defects.7 In this study, it was associated
with aortic dilatation requiring proactive repair in 20% of
patients. As the general population ages, aortic disease, in-
cluding dissection and aneurysmal disease, is becoming
more common, contributing to 43,000 to 47,000 deaths
annually in the United States.6 Earlier treatment of aortic
dilatation has therefore become paramount in preventing
aortic dissection and aneurysmal complications.
We have for a number of years proactively and aggres-
sively resected and repaired aortic dilatation associated
with bicuspid valves, but not typically at diameters smaller
than 4.5 cm. In this study, every patient with an aortic diam-
eter greater than 6.1 cm underwent repair. Indeed, 83% of
those patients with a diameter greater than approximately
4.8 cm underwent repair (Figure 1, A). Similarly, we as-
sessed aortic cross-sectional area/height ratio to indicate
when surgery is required for a dilated aorta in patients
with bicuspid valves or Marfan syndrome.9,10 We noted
that approximately 95% of those who did not undergo an
aortic procedure had a ratio less than 9.4 cm2/m, whereas
80% of those who underwent ascending aortic repair had
a ratio greater than 7.3 cm2/m. Likewise, about 95% of
patients who did not have an aortic procedure had a Z
value less than 6.9, whereas 80% of those who underwent
ascending aortic repair had a Z value greater than 5.3.
Because the aorta increases in diameter with somatic
growth, interpretation of measurements has been facilitated
by normalizing it to height or body surface area (eg, indexed
area, Z value). Indexing aortic size to these anthropomor-
phic data suggests that the cross-sectional area/height ratio
discriminates rather well those patients who need concur-
rent aortic repair. Furthermore, this ratio also takes into ac-
count the greater risk of dissection in shorter patients. We
encourage the use of this ratio for timing surgery in patients
with bicuspid aortic valves or Marfan syndrome.9,10ery c September 2011
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greater than 10 cm2/m.
With this proactive approach, 10-year freedom from as-
cending aortic events was 97.1% for the valve–aorta group
versus 99% for the valve-alone group, clearly a low risk. In-
deed, when we saw these results, we rechecked all patients’
late outcomes to ensure that no complication had been
missed. Although we see patients from our larger experi-
ence who occasionally return for reoperation on either the
aortic root or arch, this is uncommon unless aortic dissec-
tion was present at the index operation. Similarly, we see
patients who have been operated on elsewhere; the denom-
inator in this case is unknown, however, although with 1%
to 2% of the population having bicuspid valves, it is likely
large. Of note, in 2004, after the period of this study, Borger
and colleagues1 recommended that ascending aorta replace-
ment be used more often, because in their series 22 patients
developed long-term complications related to the ascending
aorta, particularly those in whom the aorta was greater than
4.5 cm. Fifteen-year freedom from complications was 43%,
81%, and 86% for aortic diameters of 4.5 to 4.9 cm, 4.0 to
4.5 cm, and smaller than 4.0 cm, respectively (P<.001).
Our study supports their hypothesis that proactive repair
of the aorta, particularly when larger than 4.5 cm in diame-
ter, reduces late risk of complications.
Reducing late complications related to aortic dilatation,
however, would not be justified if doing so carried an
increased early risk of death, stroke, or other serious com-
plications related to surgery. We therefore used several
methods, including propensity adjustment and propensity
matching, to identify risk-adjusted differences in surgical
risk between the groups. Despite this careful and detailed
analysis, we found no statistically significant difference in
early deaths or complications. Furthermore, the approxi-
mate 99% survival and 1.5% postoperative occurrence of
stroke were gratifyingly good in both groups. There is
thus no specific penalty (ie, increase in risk) associated
with concomitant repair of the aorta.
On late follow-up, patients in the valve–aorta group had
better non–risk-adjusted survival than did those in the
valve-alone group. One likely explanation is that the
valve-alone patients had more symptomatic aortic valve
disease, either stenosis or regurgitation, resulting in symp-
toms as an indication for surgery, and worse left ventricular
function (Tables 1 and E2). This raises the interesting issue
of whether earlier surgery for significant but asymptomatic
aortic valve disease might result in better long-term sur-
vival. Surgery should therefore be considered in young pa-
tients with severe valvular disease even if they show neither
symptoms nor marked left ventricular dysfunction or dilata-
tion. After propensity matching, the difference in long-term
survival was not statistically significant for the 206 matched
patient pairs. However, this propensity matching balanced
symptoms, aortic stenosis or regurgitation, and left ventric-The Journal of Thoracic and Caular dysfunction and specifically addressed whether aortic
repair affected survival. This matched analysis showed
that addition of aortic repair did not negatively affect sur-
vival. Indeed, this would not be expected, unless perhaps re-
lated to a risk of false aneurysms or graft infection, but
neither occurred. Current American College of Cardiol-
ogy/American Heart Association guidelines for aortic valve
surgery are essentially based on symptoms or measures of
left ventricular dysfunction14; the issue of asymptomatic se-
vere aortic valve disease and earlier surgery will need to be
addressed during further guideline iterations.
Limitations
This was a clinical cohort study and not a randomized
trial. A randomized trial would be difficult because of the
continuous nature of aortic diameter. We did, however,
use various methods to analyze the data and provide a fair
comparison. We found no disadvantage to concomitant as-
cending aorta repair. Aortic diameter data were not col-
lected prospectively; nevertheless, one of us (K.-H.K.)
retrieved and reviewed every preoperative echocardiogram
that did not give precise aortic diameters. Postoperative
follow-up imaging of the aorta was not performed on a rou-
tine schedule with CT or MRI, and echocardiography was
performed at the referring cardiologist’s discretion.
Recommendations
Surgical options (based on 771 repairs) depend on the sur-
geon’s experience, but in our opinion, a regurgitant bicuspid
valve should be repaired, and if the ascending aorta is also
significantly dilated (diameter larger than 4.5 cm or aortic
cross-sectional area/height ratio greater than 10 cm2/m), it
should be replaced.1-5,8,11,13-17,19 This study shows that
failure to do so is associated with an increased risk of late
aortic complications, particularly aortic dissection. If the
root is enlarged, a remodeling root-sparing operation is pre-
ferred, because often these are young patients in whom bio-
logic valves soon fail, and mechanical valves require
lifelong anticoagulation.3,13,15,19 In our experience, 10-
year freedom from reoperation for bicuspid valve repair
ranges from 79% to 83% for valve-alone procedures and
is 91% for combined valve–aorta procedures, slightly less
than for tricuspid valve repair and root-sparing or root-
preserving procedures (96% at 10 years).3,4,11,13,15,19 For
patients with aortic valve stenosis, the valve will require
replacement because attempted decalcification procedures
fail within a few years.
Proactive aortic repair is recommended at the time of bi-
cuspid aortic valve surgery when either the aortic diameter
exceeds approximately 4.5 cm, the aortic cross-sectional
area/height ratio exceeds approximately 8 to 9 cm2/m, or
the Z value exceeds 7. For patients with a bicuspid valve
not requiring surgery, we recommend aortic repair when
the aortic cross-sectional area/height ratio exceeds 10rdiovascular Surgery c Volume 142, Number 3 627
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Dcm2/m. Our data do not currently justify resecting the aorta
if it is smaller than 4.5 cm. Consideration should be given to
stress testing patients with severe bicuspid valve disease
before the development of symptoms or left ventricular dys-
function, because left ventricular mass exceeding 180 g/m2
or a left atrium exceeding 4.5 cmmay be better predictors of
late survival than are symptoms. Furthermore, patients
should be followed long term, preferably byMRI (to reduce
the risks of CT-related radiation), for late development of
aneurysm, particularly of the aortic arch.26
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Patient Variables
Demography. Age (years), sex, ethnicity, weight (kilo-
grams), height (centimeters), body surface area (square
meters), body mass index (kilograms per square
meter)
Symptoms. New York Heart Association functional class
(I–IV), emergency operation
Ventricular dysfunction. Previous myocardial infarction,
degree of left ventricular dysfunction (1, none; 2, mild; 3,
mild to moderate; 4, moderate; 5, moderately severe; 6,
severe)
Valve pathology. Aortic valve regurgitation, aortic valve
stenosis, tricuspid valve regurgitation, mitral valve regurgi-
tation
Ascending aorta. Diameter (centimeters) and its normal-
ized and standardized derivatives (diameter/height
[centimeters per meter], diameter/body surface area [centi-
meters per square meter], area [square centimeters], area/
height [square centimeters per meter], area/body mass
index [square centimeters], area/body surface area [square
centimeters per square meter], Z value)The Journal of Thoracic and CaCoronary anatomy. Left main trunk disease (percentage
stenosis), left anterior descending coronary artery system
disease (maximum percentage stenosis), right coronary
artery system disease (maximum percentage stenosis), left
circumflex coronary artery system disease (maximum
percentage stenosis)
Other cardiac comorbidity. Atrial fibrillation, hyperten-
sion, history of cardiac disease, complete heart block/pacer,
ventricular arrhythmia
Noncardiac comorbidity. Treated diabetes, insulin-
treated diabetes, history of endocarditis, history of periph-
eral arterial disease, history of smoking, carotid disease,
popliteal disease, creatinine (milligrams per deciliter),
blood urea nitrogen (milligrams per deciliter), bilirubin
(milligrams per deciliter), creatinine clearance (milliliters
per minute), hematocrit (percentage)
Experience. Date of operation (years since January 1, 1995)
Procedure Variables
Surgery type. Coronary artery bypass grafting, mitral
valve repair, mitral valve replacement, aortic valve repair,
aortic valve replacement
Procedure. Internal thoracic artery graft usedrdiovascular Surgery c Volume 142, Number 3 629
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FIGURE E1. Cumulative distribution of ascending aorta size at bicuspid
aortic valve surgery: Z value. Vertical axis represents nonparametric per-
centile; thus, the value for ascending aorta diameter at the 50% point on
the vertical axis is the median value (50th percentile), the values at 10%
and 90% are the 10th and 90th percentiles, and so forth. BAV,Bicuspid aor-
tic valve surgery alone;BAVþAo, bicuspid aortic valve surgery and ascend-
ing aorta repair.
FIGURE E2. Instantaneous risk of death (hazard function) enclosed
within 68% confidence limits. A, Whole cohort. B, Matched cohort.
BAV, Bicuspid aortic valve surgery alone; BAVþAo, bicuspid aortic valve
surgery and ascending aorta repair.
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TABLEE1. Patient characteristics, procedure details, and length of stay information for patients undergoing bicuspid aortic valve surgery with or
without ascending aorta repair
BAV alone (n ¼ 1449) BAV plus aorta (n ¼ 361)
Variable N* Value N* Value P
Demographic data
Age (y, mean  SD) 1449 56  15 361 54  14 .001
Female (no.) 1449 353 (24%) 361 66 (18%) .01
Height (cm, mean  SD) 1445 173  10 361 176  10 <.0001
Body surface area (m2, mean  SD) 1445 2.01  0.25 361 2.1  0.24 .002
Clinical acuity
New York Heart Association functional class (no.) 1449 361 <.0001
I 242 (17%) 105 (29%)
II 853 (59%) 191 (53%)
III 252 (17%) 49 (14%)
IV 102 (7.0%) 16 (4.4%)
Emergency operation (no.) 1449 13 (0.9%) 361 13 (3.6%) .0001
Cardiac comorbidity
AV regurgitation grade (no.) 1416 356 <.0001
None 328 (23%) 48 (13%)
Mild 258 (18%) 41 (12%)
Moderate 224 (16%) 61 (17%)
Moderately severe 174 (12%) 71 (20%)
Severe 432 (30%) 135 (38%)
AV stenosis grade (no.) 1331 350 <.0001
None 369 (28%) 157 (45%)
Mild 33 (2.5%) 15 (4.3%)
Mild to moderate 6 (0.45%) 2 (0.57%)
Moderate 60 (4.5%) 28 (8.0%)
Moderately severe 67 (5.03%) 23 (6.6%)
Severe 796 (60%) 125 (36%)
Previous cardiac operation (no.) 1449 174 (12%) 361 47 (13%) .6
Aortic disease (no.)
Preoperative diagnosis of aortic aneurysm 1449 27 (1.9%) 361 239 (66%) <.0001
Marfan syndrome 1449 2 (0.14%) 361 8 (2.2%) <.0001
Dilated aorta 1449 510 (35%) 361 277 (77%) <.0001
Aortic dissection 1449 2 (0.14%) 361 24 (6.6%) <.0001
Noncardiac comorbidity
Smoking (no.) 1428 749 (52%) 352 177 (50%) .5
Peripheral arterial disease (no.) 1449 329 (23%) 361 62 (17%) .02
Carotid artery disease (no.) 1449 295 (20%) 361 54 (15%) .02
Chronic obstructive pulmonary disease (no.) 1133 232 (20%) 327 51 (16%) .05
Treated diabetes (no.) 1391 127 (9.1%) 352 26 (7.4%) .3
Renal disease (no.) 1449 44 (3.04%) 361 6 (1.7%) .2
Creatinine (mg/dL, mean  SD) 1406 1.1  0.69 354 1.1  1.05 .1
Procedure
Hemiarch (no.) 1449 1 (0.07%) 361 32 (8.9%) <.0001
Arch (no.) 1449 0 (0%) 361 10 (2.8%) <.0001
AV repair (no.) 1449 206 (14%) 361 39 (11%) .09
AV replacement (no.) 1449 1243 (86%) 361 322 (89%) .09
Mechanical valve 200 (16%) 68 (21%) .03
Biologic valve 1004 (81%) 250 (78%) .2
Unknown 39 (3%) 4 (1.2%) .08
Mitral valve repair (no.) 1449 102 (7.04%) 361 17 (4.7%) .1
Coronary artery bypass grafting (no.) 1449 397 (27%) 361 76 (21%) .01
Myocardial ischemic time (min, mean  SD) 1447 74  34 361 90  35 <.0001
Cardiopulmonary bypass time (min, mean  SD) 1448 98  45 361 119  49 <.0001
(Continued)
Svensson et al Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery c Volume 142, Number 3 629.e2
A
C
D
TABLE E1. Continued
BAV alone (n ¼ 1449) BAV plus aorta (n ¼ 361)
Variable N* Value N* Value P
Length of stay (dy)
Intensive care unit 1446 1/1/3 361 1/1/3 .05
Postoperative 1449 4/6/9 361 5/6/9.9 .004
Total 1449 4/6/13 361 5/7/12 .1
BAV, Bicuspid aortic valve; AV, aortic valve. *Patients with data available. yData shown as 15th, 50th, and 85th percentiles.
TABLE E2. Ascending aorta size at time of bicuspid aortic valve surgery with or without ascending aorta repair
BAV alone (n ¼ 1449) BAV plus aorta (n ¼ 361)
Variable Mean ± SD 15th/50th/85th Percentiles Mean ± SD 15th/50th/85th Percentiles P
Diameter (cm) 3.6  0.59 3/3.6/4.2 4.8  0.94 3.9/4.8/5.6 <.0001
Diameter/height (cm/m)* 2.1  0.34 1.76/2.08/2.43 2.7  0.54 2.18/2.71/3.19 <.0001
Diameter/body surface area (cm/m2)* 1.82  0.33 1.49/1.8/2.16 2.4  0.52 1.84/2.3/2.8 <.0001
Area (cm2) 10  3.4 7.1/10/14 19  7.6 12/18/25 <.0001
Area/height (cm2/m)* 6.1  1.96 4.2/5.8/8 10  4.4 6.8/10/14 <.0001
Area/body mass index (cm2)* 0.39  0.14 0.26/0.38/0.53 0.69  0.3 0.43/0.65/0.94 <.0001
Area/body surface area (cm2/m2) 5.3  1.7 3.6/5.1/7 9.1  3.9 5.8/8.6/12 <.0001
Z value* 4.0  1.88 2.2/4.04/5.8 6.9  2.2 4.7/7.0/8.8 <.0001
Z value represents number of SDs by which aortic diameter deviated from mean expected normal diameter for patient’s body surface area. BAV, Bicuspid aortic valve. *Data
available for 1445 patients.
TABLEE3. Mortality andmorbidity for bicuspid aortic valve surgery
with or without ascending aorta repair
Variable
BAV alone
(n ¼ 1449)
BAV plus aorta
(n ¼ 361)
PNo. (%) No. (%)
In-hospital death 18 (1.2)* 4 (1.1)y >.9
In-hospital complications
Stroke 19 (1.3) 6 (1.7) .6
Return to operating room
for bleeding
75 (5.2) 21 (5.8) .6
Myocardial infarction 8 (0.55) 2 (0.55) >.9
Renal failure 12 (0.83) 2 (0.55) >.9
Prolonged ventilation 62 (4.3) 15 (4.2) .9
Septicemia or sepsis 31 (2.1) 5 (1.4) .4
BAV, Bicuspid aortic valve. *68% confidence limits 0.95% to 1.6%. y68% confi-
dence limits 0.58% to 2.0%.
TABLE E4. Influence of aortic procedure and diameter on death and
stroke
Variable Estimate ± SE P
In-hospital death
Ascending aortia surgery 0.47  0.72 .5
Ascending aortia diameter* 4.4  2.6 .1
Propensity score 0.59  1.3 .7
Intercept 5.1  0.66
In-hospital stroke
Ascending aortia surgery 0.27  0.66 .7
Ascending aortia diametery 0.23  0.81 .8
Propensity score 0.32  1.3 .8
Intercept 4.7  1.4
SE, Standard error. *(Height/area of ascending aorta), inverse transformation. As-
cending aortia area normalized by patient height. yLn(area of ascending aorta/height),
logarithmic transformation. Ascending aortia area normalized by patient height.
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